FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

372627001: Substance with chelating agent mechanism of action (substance)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1211155012 Chelating agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3646144010 Substance with chelating agent mechanism of action (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3646150017 Substance with chelating agent mechanism of action en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3723401000005112 kelerende middel da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


23 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Chelating agent Is a kelerende middel/antidot false Inferred relationship Some
Chelating agent Is a Allergen class false Inferred relationship Some
Chelating agent Is a Drug allergen false Inferred relationship Some
Chelating agent This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. A substance that forms a complex with metal ions or other substrates true Inferred relationship Some
Chelating agent Is a Substance categorized by disposition true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Edetate (substance) Is a True Chelating agent Inferred relationship Some
Deferoxamine (substance) Is a True Chelating agent Inferred relationship Some
Trientine (substance) Is a True Chelating agent Inferred relationship Some
forgiftning med kelerende middel Causative agent False Chelating agent Inferred relationship Some 1
accidentel forgiftning med kelerende middel Causative agent False Chelating agent Inferred relationship Some
tilsigtet forgiftning med kelerende middel Causative agent False Chelating agent Inferred relationship Some
forgiftning med kelerende middel, uvist med hvilken hensigt Causative agent False Chelating agent Inferred relationship Some 1
Chelating agent adverse reaction Causative agent True Chelating agent Inferred relationship Some 1
Desferrioxamine adverse reaction Causative agent False Chelating agent Inferred relationship Some
allergi over for chelerende middel Causative agent False Chelating agent Inferred relationship Some
Product containing chelating agent (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Chelating agent Inferred relationship Some 1
Dimercaprol (substance) Is a True Chelating agent Inferred relationship Some
Penicillamine (substance) Is a True Chelating agent Inferred relationship Some
Deferiprone (substance) Is a True Chelating agent Inferred relationship Some
Edetate trisodium (substance) Is a False Chelating agent Inferred relationship Some
Product containing mesna (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Product containing methionine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Product containing fomepizole (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Product containing alcohol dehydrogenase inhibitor (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Product containing mercaptamine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Product containing ipecacuanha (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
pædiatrisk ipecacuanha emetisk mikstur The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
aktivt kul oral suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Product containing Fuller's earth (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
fullerjordpulver The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Product containing sodium nitrite (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
natriumnitrit 30 mg/ml injektionsvæske, opløsning, 10 ml ampul The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
natriumthiosulfat 12,5 g/25 ml injektionsvæske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
pralidoximmesylat 200 mg/ml injektionsvæske, opløsning, 5 ml ampul The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Product containing digoxin immune fab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
protaminsulfat 50 mg/5 ml injektionsvæske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
protaminsulfat 100 mg/10 ml injektionsvæske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
flumazenil 100 µg/ml injektionsvæske, opløsning, 5 ml ampul The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Methionine 100 mg and paracetamol 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Methionine 250 mg and paracetamol 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
apomorphinhydrochlorid 10 mg/ml injektionsvæske, opløsning, ampul a 2 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
apomorphinhydrochlorid 10 mg/ml injektionsvæske, opløsning, ampul a 5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
apomorphinhydrochlorid 30 mg/3 ml fyldt pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Naltrexone hydrochloride 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
lægemidler, der anvendes til behandling af paracetamolforgiftning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
acetylcystein 200 mg/ml infusionsvæske, opløsning, ampul a 10 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Methionine 250 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Mesna 400 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Mesna 600 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
mesna 100 mg/ml injektionsvæske, opløsning, ampul a 4 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
mesna 100 mg/ml injektionsvæske, opløsning, ampul a 10 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
calciumpolystyrensulfonatpulver The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
natriumpolystyrensulfonatpulver The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Product containing sevelamer (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Product containing precisely sevelamer 400 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Product containing precisely mercaptamine (as mercaptamine bitartrate) 50 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Product containing precisely mercaptamine (as mercaptamine bitartrate) 150 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
naloxonhydrochlorid 400 µg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 1 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
naloxonhydrochlorid 400 µg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 2 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
naloxonhydrochlorid 400 µg/ml injektionsvæske, opløsning, ampul a 1 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
naloxonhydrochlorid 20 µg/ml injektionsvæske, opløsning, ampul a 2 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
calciumpolystyrensulfonatprodukt The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Product containing precisely calcium gluconate 25 milligram/1 gram conventional release cutaneous gel (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
kelerende midler og antidoter The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
kolinesterasereaktivator The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
antidot til flussyreforbrænding The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Product containing precisely activated charcoal 5 gram/1 sachet conventional release oral granules (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
aktivt kul, pulver The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Product containing protamine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Product containing ion exchange resin (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Product containing cation exchange resin (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
antidoter mod pesticider The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
bentonitpulver The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
cyanidantidot The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
cysteamin 0,1 % øjendråber The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Product containing opioid receptor antagonist (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Product containing polyvalent crotalidae antivenom (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Product containing potassium exchange resin (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
polyvalent modgift mod slanger The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
ammoniakdetoksikerende middel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Product containing heavy metal antagonist (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
natriumpolystyrensulfonat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Product containing calcium exchange resin (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Product containing sodium thiosulfate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Product containing nalorphine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Product containing Micrurus fulvius antivenom (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Product containing apomorphine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Product containing snake antivenom immunoglobulin (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
emetikum The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
natriumcellulosephosphat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Product containing naltrexone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Product containing naloxone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
antidot The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Product containing pralidoxime (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Product containing benzodiazepine receptor antagonist (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Product containing flumazenil (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Emetics The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
adsorbanter The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Cyanide poisoning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Heavy metal poisoning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Organophosphorus poisoning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
pralidoximmesylat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Polystyrene sulfonate resins The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Iron poisoning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Apomorphine hydrochloride [erectile dysfunction] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some
Apomorphine hydrochloride 2 mg sublingual tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chelating agent Inferred relationship Some

Page 1 of 3 Next End


This concept is not in any reference sets

Back to Start